Since the main pharmacological use of glucagon today is as a rescue treatment for severe hypoglycemia, especially in patients with diabetes mellitus [8], patients with VLCAD suffering from an acute metabolic crisis might also benefit from treatment with glucagon. This evidence concerns the gene GCG and very long chain acyl-CoA dehydrogenase deficiency.